Thorsten Waloschek

Thorsten Waloschek has had a long and successful career in the medical industry. Thorsten began their career in 2001 as the Head of Marketing for Dynamic Synthesis. In 2005, they moved to Novasep as the Director of Marketing. From 2006 to 2012, they worked for Draeger Medical, where they held various positions including President of the Strategic Business Field Neonatal Care & Thermoregulation, Director of Product Management PNC, and Senior Product Manager. In 2012, Thorsten moved to ANM Medical GmbH as the VP of Marketing & Sales. In 2014, they became the Senior Director of Marketing and Business Development at Natus Medical Incorporated. In 2019, they took on the role of Interim Vice President Sales and Marketing at Liberate Medical, LLC. In 2020, they became the Chief Executive Officer of NeoPrediX AG and the Interim Chief Executive Officer of BABYBE.

Thorsten Waloschek has a diverse educational background. Thorsten began their educational journey in 1983 when they attended Schillergymnasium Hannover and obtained their Abitur in 1990. Thorsten then attended IHK Köln from 1992 to 1995 and obtained their Industriekaufmann, Wirtschaftsassistent, Pharmareferent in Economics. Following this, they attended the Malik Institute for Management from 2006 to 2008 and received a Management Education. Thorsten then attended Rutgers University in 2007 and received a Management Education. In 2009, they attended Babson College and received a Management Education. In 2018, they attended Oriel Stat a Matrix and received a New Medical Device Regulation. Finally, they attended the University of Bradford from 1998 to 2000 and obtained their MBA in International Business.